Publicaciones (271) Publicaciones de Angel Luis Guerrero Peral

2024

  1. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 4

  2. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  3. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    European Journal of Neurology, Vol. 31, Núm. 5

  4. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  5. Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study

    Pain and Therapy

  6. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

2023

  1. Análisis de las alteraciones en la estructura neurofisiológica en la migraña

    CASEIB 2023. Libro de Actas del XLI Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Contribuyendo a la salud basada en valor

  2. Cefalea: concepto, diagnóstico, criterios de alerta y exploraciones complementarias

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 71, pp. 4143-4152

  3. Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project

    Neurologia, Vol. 38, pp. S22-S30

  4. Connectivity-based Meta-Bands: A new approach for automatic frequency band identification in connectivity analyses

    NeuroImage, Vol. 280

  5. Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, pp. S37-S52

  6. Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles

    Revista de neurologia, Vol. 77, Núm. 10, pp. 229-239

  7. Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine

    Neurology and Therapy, Vol. 12, Núm. 4, pp. 1319-1334

  8. Increased MRI-based Brain Age in chronic migraine patients

    Journal of Headache and Pain, Vol. 24, Núm. 1

  9. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 11

  10. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

  11. Long-term outcomes of nummular headache: A series of 168 patients and 1198 patient-years of follow-up

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 9

  12. Path Analysis Models Integrating Psychological, Psycho-physical and Clinical Variables in Individuals With Tension-Type Headache

    Journal of Pain, Vol. 24, Núm. 3, pp. 426-436

  13. Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data

    Current Pain and Headache Reports

  14. Recomendaciones de consenso para el tratamiento de la prevención de la migraña

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 246-253